World AIDS Day: SAMRC's Groundbreaking Study with MGI's DNBSEQ Technology

Offline

South Africa

Share

World AIDS Day: SAMRC's Groundbreaking Study with MGI's DNBSEQ Technology
World AIDS Day: SAMRC's Groundbreaking Study with MGI's DNBSEQ Technology

On December 1st, we acknowledged World AIDS Day, reflecting on global efforts and advancements in HIV/AIDS research.

A SAMRC (South African Medical Research Council) study explored rare HIV phenotypes in South Africa using MGI's DNBSEQ technology, Identifying specific genetic variations that may contribute to their exceptional immune response opens doors to new therapeutic strategies and personalized treatments that could benefit millions of people living with HIV.

On December 1st, we acknowledged World AIDS Day, reflecting on global efforts and advancements in HIV/AIDS research.

A SAMRC (South African Medical Research Council) study explored rare HIV phenotypes in South Africa using MGI's DNBSEQ technology, Identifying specific genetic variations that may contribute to their exceptional immune response opens doors to new therapeutic strategies and personalized treatments that could benefit millions of people living with HIV.

On December 1st, we acknowledged World AIDS Day, reflecting on global efforts and advancements in HIV/AIDS research.

A SAMRC (South African Medical Research Council) study explored rare HIV phenotypes in South Africa using MGI's DNBSEQ technology, Identifying specific genetic variations that may contribute to their exceptional immune response opens doors to new therapeutic strategies and personalized treatments that could benefit millions of people living with HIV.

On December 1st, we acknowledged World AIDS Day, reflecting on global efforts and advancements in HIV/AIDS research.

A SAMRC (South African Medical Research Council) study explored rare HIV phenotypes in South Africa using MGI's DNBSEQ technology, Identifying specific genetic variations that may contribute to their exceptional immune response opens doors to new therapeutic strategies and personalized treatments that could benefit millions of people living with HIV.

About MGI

MGI Tech Co., Ltd. (MGI) is at the forefront of global innovation, actively contributing to life science through intelligent innovation. With a presence in over 100 countries and a customer base of 2600+, MGI's cutting-edge technology has been instrumental in the development of 736+ user patents, facilitating the creation of over 150 petabytes of data. The company's extensive portfolio includes sequencing instruments, automation instruments, reagents, and related products that cater to various sectors such as life science research, agriculture, precision medicine, and healthcare.

MGI is dedicated to advancing life science tools for the healthcare of the future. As of December 2021, the company's global presence has expanded to more than 100 countries and regions, serving over 1,300 international clients. With a workforce of over 2,900 professionals worldwide, including 5 centers for research and development and production facilities in Europe, MGI is committed to fostering innovation. Approximately 35% of MGI's employees are engaged in R&D, underscoring the company's focus on pioneering advancements in the field.

The impact of MGI's work is further evidenced by the publication of over 6,800 papers in prestigious scientific journals, showcasing the significant contribution of MGI's technology to the scientific community and beyond.

For more information about MGI and its contributions to life science and healthcare, please visit the MGI website or connect with us on Twitter, LinkedIn, or YouTube.

About MGI

MGI Tech Co., Ltd. (MGI) is at the forefront of global innovation, actively contributing to life science through intelligent innovation. With a presence in over 100 countries and a customer base of 2600+, MGI's cutting-edge technology has been instrumental in the development of 736+ user patents, facilitating the creation of over 150 petabytes of data. The company's extensive portfolio includes sequencing instruments, automation instruments, reagents, and related products that cater to various sectors such as life science research, agriculture, precision medicine, and healthcare.

MGI is dedicated to advancing life science tools for the healthcare of the future. As of December 2021, the company's global presence has expanded to more than 100 countries and regions, serving over 1,300 international clients. With a workforce of over 2,900 professionals worldwide, including 5 centers for research and development and production facilities in Europe, MGI is committed to fostering innovation. Approximately 35% of MGI's employees are engaged in R&D, underscoring the company's focus on pioneering advancements in the field.

The impact of MGI's work is further evidenced by the publication of over 6,800 papers in prestigious scientific journals, showcasing the significant contribution of MGI's technology to the scientific community and beyond.

For more information about MGI and its contributions to life science and healthcare, please visit the MGI website or connect with us on Twitter, LinkedIn, or YouTube.

About MGI

MGI Tech Co., Ltd. (MGI) is at the forefront of global innovation, actively contributing to life science through intelligent innovation. With a presence in over 100 countries and a customer base of 2600+, MGI's cutting-edge technology has been instrumental in the development of 736+ user patents, facilitating the creation of over 150 petabytes of data. The company's extensive portfolio includes sequencing instruments, automation instruments, reagents, and related products that cater to various sectors such as life science research, agriculture, precision medicine, and healthcare.

MGI is dedicated to advancing life science tools for the healthcare of the future. As of December 2021, the company's global presence has expanded to more than 100 countries and regions, serving over 1,300 international clients. With a workforce of over 2,900 professionals worldwide, including 5 centers for research and development and production facilities in Europe, MGI is committed to fostering innovation. Approximately 35% of MGI's employees are engaged in R&D, underscoring the company's focus on pioneering advancements in the field.

The impact of MGI's work is further evidenced by the publication of over 6,800 papers in prestigious scientific journals, showcasing the significant contribution of MGI's technology to the scientific community and beyond.

For more information about MGI and its contributions to life science and healthcare, please visit the MGI website or connect with us on Twitter, LinkedIn, or YouTube.

About MGI

MGI Tech Co., Ltd. (MGI) is at the forefront of global innovation, actively contributing to life science through intelligent innovation. With a presence in over 100 countries and a customer base of 2600+, MGI's cutting-edge technology has been instrumental in the development of 736+ user patents, facilitating the creation of over 150 petabytes of data. The company's extensive portfolio includes sequencing instruments, automation instruments, reagents, and related products that cater to various sectors such as life science research, agriculture, precision medicine, and healthcare.

MGI is dedicated to advancing life science tools for the healthcare of the future. As of December 2021, the company's global presence has expanded to more than 100 countries and regions, serving over 1,300 international clients. With a workforce of over 2,900 professionals worldwide, including 5 centers for research and development and production facilities in Europe, MGI is committed to fostering innovation. Approximately 35% of MGI's employees are engaged in R&D, underscoring the company's focus on pioneering advancements in the field.

The impact of MGI's work is further evidenced by the publication of over 6,800 papers in prestigious scientific journals, showcasing the significant contribution of MGI's technology to the scientific community and beyond.

For more information about MGI and its contributions to life science and healthcare, please visit the MGI website or connect with us on Twitter, LinkedIn, or YouTube.

On December 1st, we acknowledged World AIDS Day, reflecting on global efforts and advancements in HIV/AIDS research.  A SAMRC (South African Medical Research Council) study explored rare HIV phenotypes in South Africa using MGI's DNBSEQ technology, Identifying specific genetic variations that may contribute to their exceptional immune response opens doors to new therapeutic strategies and personalized treatments that could benefit millions of people living with HIV.
On December 1st, we acknowledged World AIDS Day, reflecting on global efforts and advancements in HIV/AIDS research.  A SAMRC (South African Medical Research Council) study explored rare HIV phenotypes in South Africa using MGI's DNBSEQ technology, Identifying specific genetic variations that may contribute to their exceptional immune response opens doors to new therapeutic strategies and personalized treatments that could benefit millions of people living with HIV.
On December 1st, we acknowledged World AIDS Day, reflecting on global efforts and advancements in HIV/AIDS research.  A SAMRC (South African Medical Research Council) study explored rare HIV phenotypes in South Africa using MGI's DNBSEQ technology, Identifying specific genetic variations that may contribute to their exceptional immune response opens doors to new therapeutic strategies and personalized treatments that could benefit millions of people living with HIV.

About SAMRC

Established in 1969, South African Medical Research Council (SAMRC) is dedicated to improving South Africa's health through research, innovation, and technology transfer, covering laboratory investigations, clinical research, and public health studies. Focused on the quadruple burden of disease, their research informs policy, enhances practices, and uplifts the nation's health. As the largest local funder, SAMRC pioneers cutting-edge medical innovations, addressing genomic research, treatment regimens, vaccine development, diagnostics, and drug/device creation. Committed to transformation, SAMRC addresses disparities through various programs, ensuring sustainable health research capacity in South Africa. As custodians of health research, SAMRC builds a healthier nation through ongoing innovation. For more information, please visit the samrc.ac.za.

About SAMRC

Established in 1969, South African Medical Research Council (SAMRC) is dedicated to improving South Africa's health through research, innovation, and technology transfer, covering laboratory investigations, clinical research, and public health studies. Focused on the quadruple burden of disease, their research informs policy, enhances practices, and uplifts the nation's health. As the largest local funder, SAMRC pioneers cutting-edge medical innovations, addressing genomic research, treatment regimens, vaccine development, diagnostics, and drug/device creation. Committed to transformation, SAMRC addresses disparities through various programs, ensuring sustainable health research capacity in South Africa. As custodians of health research, SAMRC builds a healthier nation through ongoing innovation. For more information, please visit the samrc.ac.za.

About SAMRC

Established in 1969, South African Medical Research Council (SAMRC) is dedicated to improving South Africa's health through research, innovation, and technology transfer, covering laboratory investigations, clinical research, and public health studies. Focused on the quadruple burden of disease, their research informs policy, enhances practices, and uplifts the nation's health. As the largest local funder, SAMRC pioneers cutting-edge medical innovations, addressing genomic research, treatment regimens, vaccine development, diagnostics, and drug/device creation. Committed to transformation, SAMRC addresses disparities through various programs, ensuring sustainable health research capacity in South Africa. As custodians of health research, SAMRC builds a healthier nation through ongoing innovation. For more information, please visit the samrc.ac.za.

About SAMRC

Established in 1969, South African Medical Research Council (SAMRC) is dedicated to improving South Africa's health through research, innovation, and technology transfer, covering laboratory investigations, clinical research, and public health studies. Focused on the quadruple burden of disease, their research informs policy, enhances practices, and uplifts the nation's health. As the largest local funder, SAMRC pioneers cutting-edge medical innovations, addressing genomic research, treatment regimens, vaccine development, diagnostics, and drug/device creation. Committed to transformation, SAMRC addresses disparities through various programs, ensuring sustainable health research capacity in South Africa. As custodians of health research, SAMRC builds a healthier nation through ongoing innovation. For more information, please visit the samrc.ac.za.

DNBSEQ

COLLABORATION

WORLD AIDS DAY

SAMRC

HIV

Share this article :

Share

More Events

Join MGI at Spatial Biology UK 2024
Join MGI at Spatial Biology UK 2024
Join MGI at Spatial Biology UK 2024
Join MGI at Spatial Biology UK 2024

Mar 18, 2024

Join MGI at Spatial Biology UK 2024

Discover Genomic Innovations with MGI at Spatial Biology UK 2024! Join us on March 18th-19th at booth 15 at Novotel London West. Don't miss out!

Join us at EACR-AACR-IACR Basic and Translational Research Conference
Join us at EACR-AACR-IACR Basic and Translational Research Conference
Join us at EACR-AACR-IACR Basic and Translational Research Conference
Join us at EACR-AACR-IACR Basic and Translational Research Conference

Jan 27, 2024

Join us at EACR-AACR-IACR Basic and Translational Research Conference

Join us at booth 5 during the EACR-AACR-IACR Basic and Translational Research Conference with the MGI Team in Dublin, Ireland from February 27-29.

Join us at The Festival of Genomics & Biodata in January
Join us at The Festival of Genomics & Biodata in January
Join us at The Festival of Genomics & Biodata in January
Join us at The Festival of Genomics & Biodata in January

Jan 24, 2024

Join us at The Festival of Genomics & Biodata in January

Join us at booth 98 with MGI Tech during The Festival of Genomics & Biodata on January 24th-25th, 2024, at ExCeL in London.

Copyright © 2024 MGI tech GmbH, Ltd. All Rights Reserved.

Copyright © 2024 MGI tech GmbH, Ltd. All Rights Reserved.

Copyright © 2024 MGI tech GmbH, Ltd. All Rights Reserved.